En bloc resection of the recurrent pleural mesothelioma and reconstruction of the chest wall after immunotherapy: A case report
Open Access
- 2 September 2023
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 14 (30) , 3063-3066
Abstract
Malignant pleural mesothelioma (MPM) is associated with previous asbestos exposure, while more clinical insights into this disease have come from other case studies. Maximal cytoreduction is critical in disease control and might help to improve the prognosis. Here, a 41-year-old female presented with a 6-month history of a mass detected in the chest wall following resection of a right pleural mesothelioma 2 years previously. A fluorodeoxyglucose positron emission tomography/computed tomography scan showed a right chest wall mass with a blurred boundary 8.9 cm x 3.7 cm in size. The patient had received one cycle of bevacizumab, carboplatin, and pemetrexed, and two cycles of nivolumab, ipilimumab, and gemcitabine 5 months before admission. We subsequently resected the tumor, the involved diaphragm, and the fifth and sixth ribs, and titanium mesh and continuous suture were used to close the thoracic cage. The fixed paraffin-embedded tissues showed epithelioid pleural mesothelioma. The patient received nivolumab and ipilimumab postoperatively, and no recurrence was detected 16 months after surgery. En bloc resection with reconstructive surgery effectively removed the locally advanced malignancy and restored the biological function of the thorax with a favorable prognosis. Neoadjuvant immunotherapy might therefore be conducive to radical resection and perioperative immunotherapy might improve the prognosis. A 41-year-old female presented with a 6-month history of a chest wall mass detected after resection of a right pleural mesothelioma 2 years previously, and we resected the tumor and reconstructed the thoracic wall after neoadjuvant immunotherapy.imageKeywords
This publication has 18 references indexed in Scilit:
- Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Epidemiology of Environmental Exposure and Malignant MesotheliomaJournal of Thoracic Oncology, 2017
- Prosthetic Reconstruction of the Chest WallThoracic Surgery Clinics, 2017
- Chest wall reconstruction after extended resectionJournal of Thoracic Disease, 2016
- Chest wall stabilization and reconstruction: short and long-term results 5 years after the introduction of a new titanium plates systemJournal of Thoracic Disease, 2016
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 ClassificationJournal of Thoracic Oncology, 2016
- Updated patterns of failure after multimodality therapy for malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Abdominal Wall and Chest Wall ReconstructionPlastic and Reconstructive Surgery, 2014
- The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, MassThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest GroupJournal of Thoracic Oncology, 2011